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Summary.-Two proprietary semi-permanent hair dyes were tested for carcino-
genicity in A and DBAf mice by repeated topical applications in aqueous acetone.
Mice of both strains developed lymphoid tumours but experimental differences were
marked only in DBAf mice. A number of tumours of the ovary and uterus, and some
skin papillomas near the penis, occurred in dye-treated but not in control DBAf mice.
As many hair-dye constituents are known mutagens, adequate carcinogenicity test-
ing of these substances, and epidemiological study of exposed human populations,
are needed for evaluating possible health hazards from hair dyeing.
EXISTING methods for carcinogenicity
testing of chemicals in animals are slow
and expensive, -and quite impracticable
for monitoring the large numbers of new
and existing environmental chemicals.
Thereisconsequentlygreat current interest
in various short-term assays that, though
not capable ofproving the carcinogenicity
of a compound, may be valuable as
screening tests.
Of the battery of tests considered
necessary for adequate prescreening, at
present the most useful appear to be those
which detect chemically-induced reversion
to prototropy in amino-acid-requiring
mutants of Salmonella typhimurium and
Escherichia coli. These test have been
developed particularly by Ames and his
colleagues, who have reported the results
of testing some 300 carcinogenic and
non-carcinogenic compounds (McCann et
al., 1975; McCann and Ames, 1976).
In June 1975, independent studies were
reported by Ames, Kammen and Yama-
saki and by Searle et al., which showed
that a range of hair-dye formulations,
marketed in the U.S.A. and U.K. respec-
tively, had considerable activity as
mutagens in these bacterial tests. Various
aromatic-amine constituents of the dyes
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were also found active. Shortly afterwards,
MacPhee and Podger (1975) reported the
mutagenicity ofhair dyes soldin Australia.
There has since been much discussion
regarding the significance of these results,
which brought to the fore questions
concerning both the possible health
hazards of exposure to these widely used
dye chemicals, and the validity of the
bacterial tests as indicators of carcino-
genic activity.
Thetest carried out byAmeset al., (1975)
derived from an observation made during
a students' practical class. Those reported
by Searle et al., (1976) were carried out as
a result of animal tests of two proprietary
hair dyes, to which our attention had
been directed because of their use by a
patient at the East Birmingham Hospital
(Gyde, personal communication 1973).
The patient, a 52-year-old married
woman, presented in 1972 with anaemia
and neutropenia. Routine questioning
elicited that she had frequently used two
"semi-permanent" (non-oxidizing) hair
dyes over several years. The anaemia
responded to iron but, as expected, she
remained neutropenic. Because of a sus-
picion that the hair dyes might have been
a cause of her condition, she was advisedC. E. SEARLE AND E. L. JONES
to reduce her frequency of use, but
apparently did not do so. In 1973 she
developed acute myeloid leukaemia from
which she died.
It was, of course, realized that the
association of prolonged heavy hair-dye
usage by this patient and her disease
might be entirely fortuitous, but it was
nevertheless thought desirable to carry
out tests on the actual dyes used, for
evidence of carcinogenicity in experi-
mental animals. As these dyes are em-
ployed incorporated with detergent in a
shampoo base, the only practicable means
to test the complete preparations seemed
to be by skin application to mice, and
this was regarded as having at least some
relevance to the conditions of human
usage.
This communication reports the results
of these experiments, during which there
was a demonstration that the dyes were
mutagenic in bacteria (Searle et al., 1975).
Preliminary accounts were presented to
the British Association for Cancer
Research (Searle, Harnden and Gyde,
1]975) and elsewhere (Venitt and Searle,
1976; Searle, 1977).
MATERIALS AND METHODS
Hair dyes. These were Rimmel hair
colourant shampoos of two shades, "Golden
Silk" and "Really Brown" (referred to as GS
and RB), purchased from a large chain store.
The active ingredients were 2-nitro-p-phenyl-
enediamine (2NPPD; Colour Index 76070)
and 4-nitro-o-phenylenediamine (4NOPD;
C.I. 76021) in GS, and C.I. Acid Black 107 (an
azo-dye-metal complex) and 4-amino-2-nitro-
phenol (C.I. 76555) in RB.
GS and RB are "semi-permanent" dyes,
wNhich are used directly writhout addition of
oxidant and are gradually removed from the
hair during subsequent shampooings. They
are dark viscous fluids, used in a similar
manner to shampoos, but users are instructed
to leave the second application on the hair
for 10-15 min (GS) or 20 min (RB) for
colouring to take place. The active consti-
tuents of GS and RB are believed to be
present in many other proprietary products,
the sole reason for testing these particular
colourants being their use by the patient
referred to above.
For application to mice, one volume was
diluted with 4 parts of deionized water and
5 parts of acetone. Control mice received
aqueous acetone (500o v/v).
It -was realized that 4N\OPD has found use
as a reagent for a-oxoacids and that some
reaction of the diamines with acetone was
possible. This -was checked by thin-layer
chromatography of the aqueous acetone
dilutions of GS on Kieselgel containing
fluorescer, using chloroform/ethanol (9/1,
v/v) as solvent. 2NPPD and 4NOPD gave
sharp spots of Rf 0-65 and 0 50 respectively.
Non-UV-absorbing material, visualized by
iodine vapour, remained at the origin, and
was thought to be detergent. Heating the
diluted solution at 60-65°C for 1 h produced
a ne-w faint brown spot at Rf 0-85, and a
trace wvas also present after 3 weeks standing
at room temperature. It is not, however,
thought that any significant solvent inter-
action product was present in the solutions
as applied to the mice. Nevertheless, after the
first few weeks solutions were prepared shortly
before use instead of each 1-2 Aweeks, and
additional mice -were added to the GS-
treated groups.
Animals.-These Mwere male and female
mice of the albino A/Bcr and grey DBAf/Bcr
strains, maintained in these laboratories by
brother-sister mating for 23 and 13 years
respectively. They were kept on sterilized
sawdust in Makrolon boxes containing 5
animals and were fed modified rat/mouse
breeding cube diet (Heygate, Ltd., North-
ampton) and tap water ad libiturn.
Treatment. Mice were first treated when
6-7 weeks old. Hair was removed from their
backs with electric clippers before treatment
and at intervals thereafter as required.
The diluted dyes ws-ere applied to the
clipped back skin using 0-5 ml glass pipettes.
The volume applied was 0 4 ml per applica-
tion, reduced to 0-2 inl at 24 weeks for all
DBAf mice only, owing to toxic effects noted
below in dye-treated animals. The applica-
tions, normally t-wice weekly, totalled 138
over the 80 wreeks of the experiment. For
humani hair colouring, one 26 ml bottle is
used on each occasion. Each application of
GS or RB thus represented very approxi-
mately a 4-fold increase over the human
application on a body-weight basis (2-fold
when dose was reduced in DBAf mice).
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Mice were killed for gross and histological
examination if they showed evidence of
tumours or became sick, or at 80 weeks from
first treatment. Relatively few animals were
lost to examination through unexpected
death and autolysis, these being mostly GS-
treated mice.
Tumours and other tissues for histological
examination were fixed in formalin-acetic
acid-methanol (1: 1: 8 byvolume) andembed-
ded in paraffin wax. Sections (5 utm) were
stained with Harris' haematoxylin and eosin
and with other stains when required.
Statistical analysis.-The statistical
significances of the observed differences
between control and treated groups were
determined using the "logrank test" (Peto
et al., 1977). A survival time in weeks was
determined for each mouse and inthe context,
of the analysis, an "event" was recorded
only if death was accompanied by the
diagnosis of a tumour. Deaths from other
causes were, however, accounted for in the
figure for "extent of exposure".
Taking each mouse-strain as a group,
controls were compared with treated mice
for all tumours and separately forlymphomas.
Subsequently, comparisons in terms of
strain, sex, and dye (8 tests in all) were made
for "all tumours" alone, the numbers for
lymphoma being too small to subdivide. To
allow for the possible effect that sex might
have on prognosis, the individual results for
males and females were added to study the
total effect.
RESULTS
Toxicity
The treatments were well tolerated by
the A-strain mice and initially by the
DBAf mice also. However, between 13
and 26 weeks of treatment some male
DBAf mice became emaciated and were
killed, and the volumes applied were
therefore halved at 24 weeks in this
strain only.
The toxic effects were centred on the
urogenital tract, and may have been at
least partly due to obstruction by crystals
which were sometimes seen in the bladder
and on the skin round the penis. The
penile region was frequently distended
and in 3 mice small squamous papillomas
developed here. The bladder and seminal
vesicles were sometimes very distended
and, microscopically, dilation of renal
tubules was seen. This evidence oftoxicity
was much less common in RB-treated
mice, the times to 75% survival being 48
weeks (GS) and 64 weeks (RB). Of the
DBAf controls, 78% survived to the end
of the experiment at 80 weeks.
Many DBAf mice had noticeably dis-
tended stomachs at necropsy and histo-
logical examination showed chronic
gastritis in 3 controls, 4 GS-treated and
9 RB-treated mice.
Tumour incidence by strain
Sixty-four tumours were observed in the
treated and control mice, and times at
which they were found are summarized in
Table I. Tumours of the lymphoid system
accounted for half of those observed, and
are listed separately. An initial analysis of
the results showed a marked difference in
the pattern of tumour development
between strains. Each strainhas therefore
been considered separately.
When tumours at all sites were analysed
for Strain A mice (Table II) the observed
number of 13 tumours in controls was not
significantly different from that of 29
tumours in the two treated groups (X2 =
0 005; d.f. 1; P > 0.05), nor was there
a significant excess of lymphomas in the
treated groups (X2 0-005; d.f. - 1;P >
0.05). Further subdivision by sex and
treatment group showed equally close
correspondence between observednumbers
and "extent of exposure".
For tumours at all sites in DBAf mice
the difference between observed numbers
for controls (3) and the treated group (19)
was statistically significant (X2 = 6*06;
d.f. 1; P < 0-05). Although in this
strain only one lymphoma was observed in
controls and 8 in the treated groups, the
numbers were too small for numerical
assessment.
Tumour incidence by treatment
No statistically significant effect could
be demonstrated in Strain A mice treated
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TABLE II. Tumour Incidence in A and DBAf Mice (Both hair dyes)
Site
All tumours ()
11
Lymphomas O
E
Group
Control Test
13 29
13 21 28 79
7 16
7-16 15-84
DBAf All tumours
E
Lymphomas ()
E
0
E =
P =
x2 =
NS
NC
3 19
8 64 1:3 :36
1 8
3 24 5 76
6-06 <0 05
NC
Observed number of tumours
Exteint of exposulre
Probability of the observed difference between control and
test grouip being due to chance.
(Oc - Ec)2 (OT - ET)2
EC ET
= P > 0 05
x-x2 not compuited as E valuie too low.
Male
Femn
Boti
TABLE III. Tumnour Incidence in
DBAf Mice Treated with Dye GS
Gropl)
"ex Conitrol Test x2
3S 0 1 5 NC
E 3-32 2-86
tales 2 10 5-47 <
E 6 05 5 '95
() 3 15 9 03 <4
E 9 37 8-63
() (05
0 01
with either GS or RB. In DBAf mice
treated with RB the observed numbers
were also very close to their expectations,
but for those treated with GS the observed
number was significantly different from
that of controls (x2 =9-03; d.f. - 1;
P < 0.01) (Table III). Although the
number of tumours in males was too
small for assessment, the direction of the
difference was the same as in females, for
which a significant effect was demonstra-
ted (x2 5-47; d.f. 1; P < 0.05).
Lymphoid tumours
Although a significant excess of lym-
phoid tumours could not be demonstrated,
they were first seen from 38 weeks in
treated A mice and 26 weeks in DBAf.
The earliest tumour in control mice was
seen at week 61.
The lymphoid tumours consisted of
small uniform basophilic cells, resembling
the well-differentiated lymphocytic
lymphoma of humans. However, these
tumours appeared more malignant than
the human equivalents. They were not
confirmed to the lymph nodes, and
extensive infiltration was seen in many
organs, such as lung, liver, spleen and
kidney, closely resembling the distribution
of a leukaemic infiltrate (chronic lympho-
cytic leukaemia) in man. The renal
infiltrate was often heavy and diffuse
(Fig. 1) with extrarenal extension remini-
scent of a leukaemic infiltrate. Lymphoma
involving the spleen frequently caused
loss of the normal splenic architecture
(Fig. 2).
Female reproductive-tract tumours
These occurred in dye-treated 1)BAf
mice only. Two mice in the GS group had
uterine sarcomas. One, a pleomorphic
fibrosarcoma in a mouse killed at 66 weeks,
had become visible as a swelling in the
genital region some 18 weeks earlier. The
other, at 69 weeks, was a large, poorly
differentiated fibrosarcoma which was
widely infiltrating the uterus, with meta-
stases in the liver and lungs. This tumour
was composed of closely packed inter-
woven bundles of fusiform cells (Fig.3)
Strain
A
X02
0 -OOa
p
NS
0*00(
471C. E. SEARLE AND E. L. JONES
FIG. 1.-Female DBAf mouse, treated dye GS; 37 weeks. Heavy diffuse small-cell lymphomatous (leukaemia-like) infiltrate of kidney. Note extracapsular extension (right). H. & E. x 120.
FIG. 2.-Female A mouse, treated dye RB; 80 weeks. Splenic lymphoma showing replacement of normal architecture by sheets of small-cell lymphoma (lymphocytic lymphoma). Note multi- nucleated megakaryocyte (lower left). H. & E. x 300.
showing marked nuclear pleomorphism
and frequent mitoses.
Six dye-treated DBAf mice developed
ovarian tumours. At 80 weeks mucinous
cystadenomas ofthe ovary were found in 4
GS-treated mice, in one case in addition to
a lymphoma. These tumours were lined by
complex infolded papillary epithelium
composed of tall columnar cells with clear
cytoplasm (Fig. 4). In the RB-treated
mice an ovarian granulosa-cell tumour
was found at 79 weeks and a cystadeno-
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FIG. 3. Female DBAf mouse, treated dye GS; 69 weeks. Uterine fibrosarcoma consisting ofinterlacing
fascicles of fusiform cells infiltrating uterine muscle. H. &. E. x 120.
FIG. 4.-Female DBAf mouse, treated dye GS; 80 weeks. Mucinous cystadenoma of ovary showing
typical tall columnar cells with clear cytoplasm. H. & E. x 120.
carcinoma at 80 weeks. This tumour had
metastasized to the inguinal region and
presented with a large mass consisting of
well defined acinar structures set in a
fibrous stroma (Fig. 5).
Other tumours
No more than a single hepatoma was
found in any group. With one exception,
allthelung tumours wereinA mice. Onein
a GS-treated mouse was an adenocar-
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FIG. 5. Female DBAf mouse, treated dyeRB; 80 weeks. Metastatic o'varian cystadenocarcinoma
in inguinal nocle. H. & E. x 120.
FIG. 6. MIale DBAf mouse, treatecd clye GS; 47 weeks. Squamous papilloma of penile skin.
H. & E. x 300.
cinoma and one control lung tumour had
metastasized, but the remainder were
only small adenomas and there was
no evident relationship to the treat-
ments.
Three DBAf mice were observed with
small squamous papillomas on and around
the penis. These were all in the GS-treated
group, and it seems more likely that these,
and the associated toxic effects on the
urogenital system, may have been caused
by one or both of the nitrophenylenedia-
mines or metabolites. The penile tumours
were benign simple squamous papillomas
consisting of hvperplastic basal cells and
prickle cells (Fig. 6).
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DISCUSSION
These experiments were initiated be-
cause of a suspicion that frequent use of
hair dyes might have been responsible for
a case of acute myeloid leukaemia. It was
thought that if either dye possessed
reasonably strong carcinogenicity this
might become evident, though it was
realized that weak carcinogenicity would
be difficult to demonstrate, particularly
since any such action on organs other
than the treated skin would depend on
amounts of chemicals actually absorbed
through the skin or ingested orally as a
result of grooming.
As is seen from Table I, the main
findings were tumours of the lymphoid
system, which occurred in treated and
conitrol mice of both strains, and tumours
of the reproductive tract, which were
found in dye-treated DBAf females only.
In control A mice, the first lymphoid
tumour was found at 61 weeks, while
these occurred from 38 weeks in RB-
treated animals and from 48 weeks with
GS. The additional lymphoid tumours
found on ending the experiment at 80
weeks, however, brought the final inci-
dences to 25.000 and 21.900 in RB-treated
and control animals respectively, and to
1466% with GS treatment. The proportion
oflymphoidtumours in controls wasrather
higher than expected from previous ex-
perience with this strain, for example in an
experiment in which mice of 4strains were
treated neonatally with lV-ethyl-lV-nitro-
sourea (Searle and Jones, 1976) when only
one lymphoid tumour occurred in 15
control A mice examined post mortem.
In the DBAf mice the experimental
differences were more marked, with lym-
phoid tumours present in 5/31 (12.2%) of
GS-treated mice and 3/31 (9.70 of RB-
treated mice, compared with 1/30 (3.30o)
in controls, despite longer survival in the
latter group. Again, these tumours oc-
curred considerably earlier with dye
treatment, from 26 weeks with GS and 41
weeks with RB. Perhaps of more signifi-
cance, however, were the tumours of the
female reproductive tract which occurred
towards the end of the experiment in dye-
treated DBAf mice only. Two fibro-
sarcomas ofthe uterus, one with secondary
deposits in the liver, were found at 66 and
69 weeks in GS-treated mice, and at 79-80
weeks 4 GS mice and 2 RB mice had
ovarian tumours. Based on females exa-
mined post mortem, there were uterine or
ovarian tumours in 6/18 (33-3%) GS mice
and 2/15 (13.3%) RB mice. Ovarian
tumours in the 4 GS-treated mice were
cystadenomas. In the RB group a class-
ical mucinous cystadenocarcinoma of the
ovary had metastasized to an inguinal
lymph node, the other ovarian tumour
being a granulosa-cell tumour.
Also ofinterest in the DBAf strain were
the toxic effects on the male urinary
system, which in three instances were
accompanied by small squamous papil-
lomas of the skin near the penis. The
observations were almost entirely confined
to the GS group, and it seems likely that
they depended on one or both of the
nitrophenylenediamines or their meta-
bolic products, even though the diluted
solutions as applied contained the very
low levels of approximately 0-06%o
(4NOPD) and 0.015% (2NPPD).
Summarizing these observations, it ap-
pears that the treatments of the Strain A
mice resulted mainly in a small accelera-
tion of the appearance of "spontaneous"
lymphoid tumours. In DBAf mice, how-
ever, there was both an earlier appearance
and an increased incidence of tumours.
The excess was due mainly to uterine,
ovarian and skin tumours which were not
seen in the control group. Although no
statistically significant excess of lympho-
mas could be demonstrated because of
small numbers, the occurrence of one
lymphoma in controls and 8 in the treated
mice enhanced the total effect, indicating
that the treatments appeared to have
been carcinogenic for DBAf mice.
However, the applications were made
using relatively complex mixtures and,
with the possible exception of the skin
papillomas, the tumours cannot with
confidence be attributed to particular dye
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components ofthe colourant preparations.
Unfortunately, true control solutions, con-
taining detergent etc. but not the active
ingredients, were not available. Though
there was a specific reason for conducting
the tests reported here, animal testing of
whole proprietary colourants seems a
generallyunpromising approach because of
the very large numbers of such products,
their complex nature, and of severe
limitations on the amounts which can be
administered and on the practicable
routes of administration. Firm evidence
regarding the carcinogenicity of the vari-
ous aromatic amino compounds used in
hair colourants will have to come from
separate tests of the individual chemicals.
The chief reason for suspecting that a
number of hair dye constituents might be
carcinogenic is their definite activity in a
number of short-term screening tests,
especially in the "Ames test" using
bacterial mutants (Ames et al., 1975;
Searle et al., 1975). Tests of some 300
carcinogens and non-carcinogens in the
bacterial system showed a wide measure of
qualitative agreement between mutagenic
and carcinogenic activities (McCann et al.,
1975; McCann and Ames 1 976) while in an
important comparative study of 6 short-
term tests for carcinogen detection
(Purchase et al., 1976) tests for bacterial
mutagenicity and for cell transformation
in vitro showed the most consistent
correlations with the presence or absence
of carcinogenic activity.
However, only in the case of 2,4-di-
aminotoluene (m-toluylenediamine) has
reasonably firm evidence of carcino-
genicity been reported to date from
animal tests. This dye, now no longer used
in hair dyes in the U.S.A. (Burnett et al.,
1975) was found to give rise to sarcomas
on injection into rats (Umeda, 1955) and
to liver carcinomas on feeding to rats (Ito
et al., 1969). It was recently claimed to be
non-carcinogenic when applied to mouse
skin (Giles, Chung and Kommineni, 1976)
but this conclusion has been sharplv
criticized by Bridges and Green (1976)
because of the small numbers of animals
in the individual groups and the high
incidence of tumours in control animals.
They noted that overall there was a
greater incidence of tumours in treated
animals than in controls, and pointed out
that failure to demonstrate a statistically
significant increase in tumour yield does
not necessarily justify a claim of non-
carcinogenicity.
A very important factor in carcino-
genicity testing of environmental mate-
rials is that of the dose level to be admin-
istered. Widely divergent views have been
expressed on this. Reporting on the
effects of applying mixtures of hair-dye
components to mouse skin, Burnett et al.
(1975) list reasons why they consider
product-evaluation studies must involve
conditions of use to obtain meainingful
results. An advisory committee of the
U.S. Food and Drugs Administration
reporting on carcinogeniicity testing of
food additives and pesticides (1971),
however, considered that tests should be
carried out using doses and conditions
likely to yield maximum tumourincidence.
This will often mean the use of dosages
several orders of magnitude above the
levels encountered by man. Weisburger
(1976) has stressed the importance of
establishing maximum tolerated doses at
an early stage in carcinogenicity testing,
and pointed out that even with the firmly
established human carcinogen 2-naph-
thylamine high doses were necessary to
reproduce the human condition in animals.
The view expressed by Burnett et al.
(1975) appears at first sight quite reason-
able. However, having regard to factors
such as the need to recognize weak as well
as strong carcinogens and the common
occurrence of spontaneous tumours in
control animals, it seems clear that
carcinogenicitv tests which are limited to
environmental levels are, on any practic-
able scale, incapable of giving assurances
of safety of products used by millions of
people. Moreover, when complex formula-
tions are employed, as in the experiments
of Burnett et al. (1975) and Kinkel and
Holzmann (1973), as well as in the experi-
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ments reported here, it may be impossible
to decide which substance is responsible
for any effect that is detected without
further prolonged experimentation. It is,
of course, because of the many difficulties
involved in testing large numbers of
environmental materials that there is
such great current interest in the various
short-term screening tests (Montesano,
Bartsch and Tomatis, 1976; Purchase et
al., 1976).
A further and more direct approach to
obtaining information on possible adverse
effects ofenvironmental materials becomes
practicable when, as in the case of hair
dyes, they have had widespread use for
one or more decades. This is, of course, to
conduct epidemiological studies directly
on the exposed human populations. As
persons engaged in dyeing in the hair-
dressing trade are exposed to considerably
greater levels than are individual home
dyers, these represent the population
which it is probably most useful to study,
and this in now being done in this country.
National mortality trends for some major
cancers are sometimes quoted (e.g. Corbett,
1976) as failing to provide evidence for a
carcinogenic effect of hair dyes. Ex-
perience with important occupational
carcinogens such as 2-naphthylamine sug-
gests, however, that such data could only
reasonably be expected to reveal a massive
increase in a common cancer or the
induction of a normally very rare one, and
that valid epidemiological evidence is
only likely to come from properly planned
and conducted comparisons of exposed
and non-exposed populations.
A number of aromatic amines used in
hair dyes are well-known sensitizing agents
(Hunter, 1975) and oxidizing (permanent)
hair dyes are marketed with warnings that
patch tests for sensitivity should be
carried out before use. It has recently been
suggested that some cases of aplastic
anaemia may have resulted from hair-dye
usage (Hamilton and Sheridan, 1976;
Hans, 1976) though this view was contes-
ted by Jouhar (1976). This is a further
area in which proper epidemiological
study is necessary before we can expect to
have a comprehensive picture of the
health aspects of the present very large-
scale usage of hair dyes.
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